DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cesamet (Nabilone) - Published Studies

 
 



Cesamet Related Published Studies

Well-designed clinical trials related to Cesamet (Nabilone)

Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers. [2010.11]

A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. [2010.05]

The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. [2010.02.01]

A pilot study using nabilone for symptomatic treatment in Huntington's disease. [2009.11.15]

Analgesic and antihyperalgesic effects of nabilone on experimental heat pain. [2008.04]

Nabilone for the treatment of pain in fibromyalgia. [2008.02]

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. [2008.01.26]

Nabilone for the Treatment of Pain in Fibromyalgia. [2007.10.30]

Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial. [2006.10]

Effects of nabilone, a synthetic cannabinoid, on postoperative pain. [2006.08]

[Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial] [2006.06]

The effect of nabilone on neuropsychological functions related to driving ability: an extended case series. [2005.06]

Effect of nabilone on nausea and vomiting after total abdominal hysterectomy. [1994.08]

A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. [1988.04]

A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea. [1987.09]

Well-designed clinical trials possibly related to Cesamet (Nabilone)

Examining the roles of cannabinoids in pain and other therapeutic indications: a review. [2010.01]

Examining the roles of cannabinoids in pain and other therapeutic indications: a review. [2010]

Are cannabinoids a new treatment option for pain in patients with fibromyalgia? [2008.07]

Are cannabinoids a new treatment option for pain in patients with fibromyalgia? [2008.06.03]

Cannabinoids in medicine: A review of their therapeutic potential. [2006.04.21]

Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. [2002.01]

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. [2001.12.11]

Other research related to Cesamet (Nabilone)

An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy. [2011.07]

Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating delta9-tetrahydrocannabinol. [2010.09]

The abuse potential of the synthetic cannabinoid nabilone. [2010.03]

A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. [2010]

The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. [2010]

Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers. [2009.06.12]

Nabilone for the treatment of paraneoplastic night sweats: a report of four cases. [2008.07]

Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. [2008.03]

Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain. [2008.01]

Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. [2006.01]

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. [2002.01]

Other possibly related research studies

The emerging role of cannabinoid neuromodulators in symptom management. [2007.01]

Guidelines for the use of cannabinoid compounds in chronic pain. [2005.09]

Cannabinoids and multiple sclerosis. [2002.08]

Cannabis and cannabinoids: pharmacology and rationale for clinical use. [1999.10]

Pharmacokinetic optimisation of antiemetic therapy. [1992.08]

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure. [2006.10]

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. [2006.02]

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. [2005.05]

[Cannabinoids and the immune system. Of men, mice and cells] [2004.06]

Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. [2003]

Medical marijuana initiatives : are they justified? How successful are they likely to be? [2003]

Therapeutic potential of cannabinoids in CNS disease. [2003]

Cannabinoids for gastrointestinal diseases: potential therapeutic applications. [2003.01]

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. [2001.07.07]

Cannabinoids in clinical practice. [2000.12]

Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A. [2001.02]

Laboratory detection of cannabinoids. [1987.09]

Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. [2007.05]

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions. [2007.06]

Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances. [2007.09]

Reassessment of the role of cannabinoids in the management of pain. [2007.10]

Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. [2008.07.03]

Cannabinoids in the management of difficult to treat pain. [2008.02]

Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. [2008.09]

[What sense in cannabinoid use as regulated by Italian DM 18/04/07? Pharmacological and legal considerations] [2008.06]

Chemotherapy-induced nausea and vomiting. [2008.03]

Fungal biotransformation of cannabinoids: potential for new effective drugs. [2009.03]

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. [2009.02]

The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). [2009.01]

Emerging strategies for exploiting cannabinoid receptor agonists as medicines. [2009.02]

Cannabinoids, endocannabinoids, and related analogs in inflammation. [2009.03]

[Cannabinoids in medicine] [2008]

A treatment algorithm for neuropathic pain: an update. [2009.12]

Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines. [2010]

Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists. [2010.01]

Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. [2009.10]

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. [2011.11]

Using cannabinoids in pain and palliative care. [2010.10]

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. [2011]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017